1. Serum inflammatory factors and circulating immunosuppressive cells are predictive markers for efficacy of radiofrequency ablation in non-small-cell lung cancer. (15th April 2015) Authors: Schneider, T; Sevko, A; Heussel, C P; Umansky, L; Beckhove, P; Dienemann, H; Safi, S; Utikal, J; Hoffmann, H; Umansky, V Journal: Clinical and experimental immunology Issue: Volume 180:Number 3(2015:Jun.) Page Start: 467 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗